Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francois Aubin

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Cancers|June 27, 2020
Combined Therapy with Anti-PD1 and BRAF and/or MEK Inhibitor for Advanced Melanoma: A Multicenter Cohort StudySandra Huynh, Laurent Mortier, Caroline Dutriaux, et al.
Virchows Archiv : an International Journal of Pathology|March 30, 2018
Detection of the Merkel cell polyomavirus in the neuroendocrine component of combined Merkel cell carcinomaThibault Kervarrec, Mahtab Samimi, Pauline Gaboriaud, et al.
Archives of Dermatology|May 21, 2008
Variations in management of stage I to stage III cutaneous melanoma: a population-based study of clinical practices in FranceFlorent Grange, Fabien Vitry, Florence Granel-Brocard, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 24, 2018
Diagnostic accuracy of a panel of immunohistochemical and molecular markers to distinguish Merkel cell carcinoma from other neuroendocrine carcinomasThibault Kervarrec, Anne Tallet, Elodie Miquelestorena-Standley, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 16, 2019
Morphologic and immunophenotypical features distinguishing Merkel cell polyomavirus-positive and negative Merkel cell carcinomaThibault Kervarrec, Anne Tallet, Elodie Miquelestorena-Standley, et al.
Cancers|July 2, 2021
Tolerance and Effectiveness of Targeted Therapies in Aged Patients with Metastatic MelanomaOndine Becquart, Bastien Oriano, Stéphane Dalle, et al.
Histopathology|October 13, 2023
Detection of wildtype Merkel cell polyomavirus genomic sequence and VP1 transcription in a subset of Merkel cell carcinomaThibault Kervarrec, Silke Appenzeller, Anne Tallet, et al.
The Lancet. Respiratory Medicine|May 25, 2019
Long-term treatment with recombinant human pentraxin 2 protein in patients with idiopathic pulmonary fibrosis: an open-label extension studyGanesh Raghu, Bernt van den Blink, Mark J Hamblin, et al.
The Journal of Investigative Dermatology|September 4, 2021
Merkel Cell Polyomavirus‒Negative Merkel Cell Carcinoma Originating from In Situ Squamous Cell Carcinoma: A Keratinocytic Tumor with Neuroendocrine DifferentiationThibault Kervarrec, Silke Appenzeller, Mahtab Samimi, et al.
The British Journal of Dermatology|July 14, 2025
Neoadjuvant immune checkpoint inhibitors for patients with resectable stage III/IV melanoma: A nationwide real-life study in France (NEOMEL)Charlée Nardin, Charlotte Cavalieri, Céleste Lebbé, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Cancers|June 27, 2020
Combined Therapy with Anti-PD1 and BRAF and/or MEK Inhibitor for Advanced Melanoma: A Multicenter Cohort StudySandra Huynh, Laurent Mortier, Caroline Dutriaux, et al.
Virchows Archiv : an International Journal of Pathology|March 30, 2018
Detection of the Merkel cell polyomavirus in the neuroendocrine component of combined Merkel cell carcinomaThibault Kervarrec, Mahtab Samimi, Pauline Gaboriaud, et al.
Archives of Dermatology|May 21, 2008
Variations in management of stage I to stage III cutaneous melanoma: a population-based study of clinical practices in FranceFlorent Grange, Fabien Vitry, Florence Granel-Brocard, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 24, 2018
Diagnostic accuracy of a panel of immunohistochemical and molecular markers to distinguish Merkel cell carcinoma from other neuroendocrine carcinomasThibault Kervarrec, Anne Tallet, Elodie Miquelestorena-Standley, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 16, 2019
Morphologic and immunophenotypical features distinguishing Merkel cell polyomavirus-positive and negative Merkel cell carcinomaThibault Kervarrec, Anne Tallet, Elodie Miquelestorena-Standley, et al.
Cancers|July 2, 2021
Tolerance and Effectiveness of Targeted Therapies in Aged Patients with Metastatic MelanomaOndine Becquart, Bastien Oriano, Stéphane Dalle, et al.
Histopathology|October 13, 2023
Detection of wildtype Merkel cell polyomavirus genomic sequence and VP1 transcription in a subset of Merkel cell carcinomaThibault Kervarrec, Silke Appenzeller, Anne Tallet, et al.
The Lancet. Respiratory Medicine|May 25, 2019
Long-term treatment with recombinant human pentraxin 2 protein in patients with idiopathic pulmonary fibrosis: an open-label extension studyGanesh Raghu, Bernt van den Blink, Mark J Hamblin, et al.
The Journal of Investigative Dermatology|September 4, 2021
Merkel Cell Polyomavirus‒Negative Merkel Cell Carcinoma Originating from In Situ Squamous Cell Carcinoma: A Keratinocytic Tumor with Neuroendocrine DifferentiationThibault Kervarrec, Silke Appenzeller, Mahtab Samimi, et al.
The British Journal of Dermatology|July 14, 2025
Neoadjuvant immune checkpoint inhibitors for patients with resectable stage III/IV melanoma: A nationwide real-life study in France (NEOMEL)Charlée Nardin, Charlotte Cavalieri, Céleste Lebbé, et al.
Pageof 3